Journals / MN Oftalmoloji / 2012 / Cilt: 19 - Sayı: 3

Efficiency of posterior subtenon and intravitreal triamcinolone acetonide for visual acuity and macular edema in the treatment of uveitis

Posterior subtenon ve intravitreal triamsinolon asetonid kullanımının üveit tedavisinde görme keskinliği ve maküla ödemi üzerindeki etkinliği

Pages
181–185
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Macular edema regression was more at the end of 1st month for intravitreal injection compared to posterior subtenon injection however no difference was observed at the end of 6th month.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To research effects and compare efficiency of 4mg/0.1ml intravitreal and 20mg/0.5ml posterior subtenon triamcinolone acetonide treatment on visual acuity and macular edema in the treatment of posterior and intermediate uveitis.
📊
Key Findings & Data:Material and Method: Eighty six eyes of 69 patients’ records, which were treated for posterior and intermediate uveitis due to various reasons, were reviewed for this prospective study.
💡
Conclusion & Impact:Macular edema regression was more at the end of 1st month for intravitreal injection compared to posterior subtenon injection however no difference was observed at the end of 6th month.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: To research effects and compare efficiency of 4mg/0.1ml intravitreal and 20mg/0.5ml posterior subtenon triamcinolone acetonide treatment on visual acuity and macular edema in the treatment of posterior and intermediate uveitis. Material and Method: Eighty six eyes of 69 patients&#8217; records, which were treated for posterior and intermediate uveitis due to various reasons, were reviewed for this prospective study. Forty two patients were treated with intravitreal (IVTA) and 44 patients were treated with posterior subtenon (PSTA) triamcinolone. Clinical assessments were performed on 3 control periods. The control periods were 1 month, 3 months and 6 months after treatment. During control assessments visual acuity by logMAR and intraocular pressure by applanation tonometry was evaluated, anterior segment and fundus were examined by bio microscope. When deemed necessary fundus fluorescein angiography (FFA) was done. Results: The average levels of visual acuity before intravitreal injection according to logMAR were 0.68±0.50. The results were 0.55±0.48 at the end of 1st month, 0.27±0.38 at the end of 3rd month, 0.27±0.38 at the end of 6th month. The average levels of visual acuity before posterior subtenon injection according to logMAR were 0.69±0.49. The results were 0.47±0.44 at the end of 1st month, 0.36±0.44 at the end of 3rd month, 0.34±0.45 at the end of 6th month. There was no statistically significant difference between groups (p>0.05). Regression of macular edema on IVTA group was more than PSTA group by the end of 1st month (p<0.05). Conclusion: Intravitreal and posterior subtenon triamcinolone injection in the treatment of macular edema due to uveitis is an efficient and safe method. Macular edema regression was more at the end of 1st month for intravitreal injection compared to posterior subtenon injection however no difference was observed at the end of 6th month.

Özet

Amaç: Bu çalışmanın amacı; arka ve orta üveit tedavisinde 4mg/0,1ml intravitreal (İVTA) ve 20mg/0,5m posterior subtenon triamsinolon asetonid tedavisinin görme keskinliği, maküla ödemi üzerindeki etkilerini araştırmak ve karşılaştırmaktır. Gereç ve Yöntem: Bu prospektif çalışmada değişik nedenlere bağlı gelişen arka ve orta üveit sebebiyle tedavi edilen 69 hastanın 86 gözüne ait kayıtlar tarandı. Kırk iki hastaya intravitreal, 44 hastaya posterior subtenon triamsinolon (PSTA) uygulandı. Klinik değerlendirmeler 3 kontrol aralığında yapıldı. Birinci kontrol aralığı 1 ay, ikinci kontrol aralığı 3 ay, üçüncü kontrol aralığı 6 ay sonraydı. Kontrol muayenelerinde logMar’a göre görme keskinlikleri, biyomikroskopla ön segment ve fundus muayenesi, aplanasyon tonometrisi ile göz içi basınç ölçümleri yapıldı. Gerekli görülen hastalarda fundus flöresein anjiyografi (FFA) yapıldı. Bulgular: Görme keskinliği ortalaması; intravitreal enjeksiyon yapılanlarda enjeksiyon öncesi logMAR’a göre 0,68±0,50, enjeksiyon sonrası 1. ay sonunda 0,55±0,48, 3. ay sonunda 0,27±0,38, 6. ay sonunda 0,27±0,38 olarak ölçüldü. Subtenon enjeksiyon yapılanlarda ise, enjeksiyon öncesi logMAR’a göre 0,69±0,49, enjeksiyon sonrası 1. ay sonunda 0,47±0,44, 3. ay sonunda 0,36±0,44 6. ay sonunda 0,34±0,45 olarak ölçüldü. Gruplar arasında istatistiksel olarak fark saptanmadı (p>0,05). İVTA grubunda maküla ödemindeki gerileme 1. ay sonunda daha fazlaydı (p<0,05). Sonuç: İntravitreal ve arka subtenon triamsinolon enjeksiyonu üveite bağlı maküla ödemi tedavisinde etkili ve güvenilir yöntemlerdir. Enjeksiyon sonrası 1. ayda intravitreal enjeksiyon yapılanlarda arka subtenon enjeksiyon yapılanlara göre maküla ödemi gerilemesi daha belirgin iken 3 ve 6 ay sonunda fark görülmedi.

🔖

Cite This Article

ÖZEK, D., YAZAR, Z. (2012). Efficiency of posterior subtenon and intravitreal triamcinolone acetonide for visual acuity and macular edema in the treatment of uveitis. MN Oftalmoloji, Cilt: 19 - Sayı: 3, 181–185. https://ajindex.com/articles/295730

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Young S, Larkin G, Branley M, Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular edema in uveitis. Clin Experiment Ophthalmol 2001;29:2-6 2. Jonas JB. Intravitreal triamcinolone acetonide: A change in paradigm. Ophthalmic Res 2006;38:218-45 3. Choudhry S, Ghosh S. Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema. Clin Experiment Ophthalmol 2007;35:713-8. 4. Atmaca LS, Yalçındağ FN. Intravitreal triamcinolone acetonide in the management of cystoid macular edema in Behçet's disease. Graefes Arch Clin Exp Ophthalmol 2007;245:451-6. 5. Sallam A, Comer RM. Short-term safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema in children. Arch Ophthalmol 2008;126:200-5. 6. Tuncer S, Yılmaz S. Results of intravitreal triamcinolone acetonide (IVTA) injection for the treatment of panuveitis attacks in patients with Behçet disease. J Ocul Pharmacol Ther 2007; 23:395-401 7. Okada AA, Wakabayashi T. Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis. Br J Ophthalmol 2003;87:968-71 8. Göncü T, Özdek Ş. Üveitlerin tedavisinde posterior subtenon triamsinolon kullanımının etkinliği ve komplikasyonları Re - tina-Vitreus 2007;15:35-9 9. Tanner V, Kanski JJ, Frith PA. Posterior sub-tenon’s triamcinolone injections in the treatment of uveitis. Eye 1998;12: 579-685. 10. Helm CJ, Holland GN. The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 1995;120:55-64 11. Özkiriş A, Erkılıç K. Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol 2005;40:63-8.